Pyranocoumarins isolated from Peucedanum praeruptorum as differentiation inducers in human leukemic HL-60 cells

Planta Medica

Volumn 69, Issue 3, 2003, Pages 223-229

  Zhang, Jin Xia ^a   Fong, Wang Fun ^a   Yiu Cheong Wu, Jimmy ^a   Yang, Mengsu ^a   Cheung, Hon Yeung ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apiaceae; Differentiation; HL 60; MEK ERK pathways; p27kip1; Peucedanum praeruptorum; Pyranocoumarins

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4' O ACETYL 3' O ANGELOYLKHELLACTONE; ANGULAR PYRANOCOUMARIN; CD11B ANTIGEN; CD14 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITROBLUE TETRAZOLIUM; PEUCEDANUM PRAERUPTORUM EXTRACT; PROTEIN P27; PYRANOCOUMARIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN HL 60; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PROTEIN EXPRESSION; STRUCTURE ANALYSIS; UPREGULATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APIACEAE; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; PHYTOTHERAPY; PLANT PREPARATIONS; PYRANOCOUMARINS; TUMOR SUPPRESSOR PROTEINS;

APIACEAE; PEUCEDANUM; PEUCEDANUM PRAERUPTORUM;

EID: 0037363645     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38490     Document Type: Article

References (17)

1. Chen ZX, Huang BS, She QL, Zeng GF. The chemical constituents of Bai-Hua-Qian-Hu, the root of Peucedanum praeruptorum Dunn (Umbelliferae) - four new coumarins. Yao Xue Xue Bao (Acta Pharmaceutica Sinica) 1979; 14: 486-96
2. Okuyama T, Shibata S. Studies on coumarins of a Chinese drug "Qian-Hu". Planta Med 1981; 42: 89-96
3. 4. Chem Pharm Bull 1995; 43: 859-67
4. Nishino H, Okuyama T, Takata M, Shibata S, Tokuda H, Takayasu J, Hasegawa T, Nishino A, Ueyama H, Iwashima A. Studies on the anti-tumor-promoting activity of natural occurring substances. IV. Pd-11 [(+)anomalin, (+)praeruptorin B], a seselin-type coumarin, inhibits the promotion of skin tumor formation by 12-O-tetradecanoylphorbol 13-acetate in 7,12-dimethylbenz[a]anthracene-initiated mice. Carcinogenesis 1990; 11: 1557-61
5. Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M. Effect of coumarins on HL60 cell differentiation. Anticancer Res 2000; 20: 2505-12
6. Bruggisser R, von Daeniken K, Jundt G, Schaffner W, Tullberg-Reinert H. Interference of plant extracts, phytoestrogens and antioxidants with the MTT tetrazolium assay. Planta Med 2002; 68: 445-8
7. 3-induced differentiation of HL60 cells. J Cell Biochem 2001; 80: 471-82
8. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936-40
9. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85
10. Nagata U, Rakahashi N, Davis RJ, Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 1998; 92: 1859-69
11. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD98059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 1995; 270: 27489-94
12. Menger H, Yuchen Y, Shurong C, Jinren C, Jia-xiang L, Lin Z, Longjun G, Zhenyi W. Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-72
13. Reiss M, Gamba-Vitalo C, Sartorelli AC. Induction of tumor cell differentiation as a therapeutic approach: Preclinical models for hematopoietic and solid neoplasms. Cancer Treat Rep 1986; 70: 201-18
14. 3: A new class of potent inhibitors of proliferation of prostate, breast, an myeloid leukemic cells. Cancer Res 1999; 59: 4023-9
15. Kharbanda S, Saleem A, Emoto Y, Stone R, Rapp U, Kufe D. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myloid leukemia cells. J Biol Chem 1994; 269: 872-8
16. Yen A, Roberson MS, Varvayanis S, Lee AT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrested. Cancer Res 1998; 58: 3163-72
17. Yen A. Control of HL-60 myeloid differentiation. Evidence of uncoupled growth and differentiation control, S-phase specificity, and two-step regulation. Exp Cell Res 1985; 156: 198-212